Skip to main navigation

Back to SpringWorksTx.com
Investors & Media
Contact Us
Linkedin
Twitter

Overview
News & Events
- Press Releases
- Events & Presentations
Corporate Governance
Financial Information
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Investor Resources
Investors + Media
Medical Professionals
Contact Us
Linkedin
Twitter

Press Releases

Items Per Page

Year

08 Dec 2023

SpringWorks Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

PDF Version

05 Dec 2023

SpringWorks Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

PDF Version

04 Dec 2023

SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock

PDF Version

29 Nov 2023

SpringWorks Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference

PDF Version

27 Nov 2023

SpringWorks Therapeutics Announces FDA Approval of OGSIVEO™ (nirogacestat) as the First and Only Treatment for Adults with Desmoid Tumors

PDF Version

16 Nov 2023

SpringWorks Therapeutics Announces Positive Topline Results from the Phase 2b ReNeu Trial of Mirdametinib in NF1-PN

PDF Version

02 Nov 2023

SpringWorks Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

PDF Version

01 Nov 2023

SpringWorks Therapeutics Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat in Adults with Desmoid Tumors at the 2023 CTOS Annual Meeting

PDF Version

11 Sep 2023

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer

PDF Version

02 Aug 2023

SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

PDF Version

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 1 - 10 of 131

Springworks - Toolkits

Print Page
Email Alerts
RSS Feeds
Investor Contacts

Request E-mail Alerts

Social Links

Footer 1

Who We Are
Focus Areas

Footer 2

Pipeline
Careers
- View Opportunities

Footer 3

Patients
Contact

Footer 4

Investors & Media

© 2023 SpringWorks Therapeutics. All rights reserved.

Copyright Links

Privacy Policy
Terms of Use
Cookie Policy